Improved Patient Recovery After Anesthesia With Hypercapnia Hyperpnoea

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Hypercapnia
Interventions
OTHER

standard of care for phase one anesthesia care

Patients received intravenous fentanyl at the discretion of the attending anesthesiologist. Anesthesia was induced with a remifentanil infusion, lidocaine, propofol, and rocuronium or succinylcholine at the anesthesiologist's discretion. Maintenance anesthesia was 6% end tidal desflurane with oxygen flows of 2 L/min (though clinicians could deviate from this at their discretion). Clinicians were directed to maintain blood pressure at ±20% of baseline. A baseline remifentanil infusion was used throughout each case, and both remifentanil and fentanyl were titrated at the anesthesiologist's discretion. Ventilation was adjusted to maintain an end tidal carbon dioxide concentration (EtCO2) of 35 mmHg. Ondansetron 4 mg was given prophylactically before the end of surgery.

DEVICE

Quick Emergence Device

The Quick Emergence Device is placed between the endotracheal tube and the anesthesia breathing circuit to enable hypercapnia when ventilation is increased. The end-tidal gas sampling line is connected between the device and the endotracheal tube connector. Minute ventilation is doubled and the EtCO2 is elevated to approximately 48 mmHg from the previous maintenance level of 35 mmHg.

Trial Locations (1)

84132

University of Utah, Salt Lake City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Anecare

INDUSTRY

lead

University of Utah

OTHER

NCT00708526 - Improved Patient Recovery After Anesthesia With Hypercapnia Hyperpnoea | Biotech Hunter | Biotech Hunter